High Durable CR Rates and Preliminary Safety Profile for JCAR017 in R/R Aggressive B-NHL (TRANSCEND NHL 001 Study): A Defined Composition CD19-Directed CAR T Cell Product with Potential for Outpatient Administration
暂无分享,去创建一个
Michael L. Wang | L. Gordon | D. Maloney | M. Lunning | T. Siddiqi | J. Abramson | A. Forero-Torres | M. Palomba | J. Arnason | Daniel H. Li | Jacob Garcia | B. Xie | C. Dehner | T. Albertson